Vinik, A I <br/><br/>
The use of somatostatin analog in gastroenteropancreatic tumors other than carcinoid.  [electronic resource] 

 -  Metabolism: clinical and experimental  Sep 1990 
 - 156-62 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0026-0495 
<br/><br/><label>Standard No.: </label>10.1016/0026-0495(90)90236-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Bone Neoplasms--secondary<br/>Combined Modality Therapy<br/>Female<br/>Gastric Acid--metabolism<br/>Gastrinoma--drug therapy<br/>Gastrins--metabolism<br/>Gastrointestinal Neoplasms--drug therapy<br/>Humans<br/>Liver Neoplasms--secondary<br/>Male<br/>Octreotide--adverse effects<br/>Pancreatic Neoplasms--drug therapy<br/>Paraneoplastic Endocrine Syndromes--drug therapy